Published in BMJ on February 24, 1996
Apple phytochemicals and their health benefits. Nutr J (2004) 2.24
Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr (2012) 2.24
Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res (2009) 2.00
Exogenous antioxidants-Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev (2016) 1.71
Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients (2010) 1.66
Fruits, vegetables and coronary heart disease. Nat Rev Cardiol (2009) 1.47
Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J Am Diet Assoc (2009) 1.46
Production of plant-specific flavanones by Escherichia coli containing an artificial gene cluster. Appl Environ Microbiol (2003) 1.45
Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol (2001) 1.45
Chocolate and prevention of cardiovascular disease: a systematic review. Nutr Metab (Lond) (2006) 1.40
Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2008) 1.34
Scientific production of Sports Science in Iran: A Scientometric Analysis. Acta Inform Med (2014) 1.34
A comprehensive review of apples and apple components and their relationship to human health. Adv Nutr (2011) 1.25
Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr Rev (2012) 1.23
Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin Pharmacol (2001) 1.21
Intakes of fruits, vegetables and carbohydrate and the risk of CVD. Public Health Nutr (2008) 1.13
Grapes and cardiovascular disease. J Nutr (2009) 1.09
Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion. J Am Coll Cardiol (2010) 1.09
Recent advances and uses of grape flavonoids as nutraceuticals. Nutrients (2014) 1.08
Flavonoids and heart disease. BMJ (1996) 1.07
Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. Adv Nutr (2012) 1.05
(-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways. Ann Clin Transl Neurol (2014) 1.04
Estimated dietary intake and major food sources of polyphenols in the Polish arm of the HAPIEE study. Nutrition (2014) 1.03
Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat (2008) 1.03
Adjunctive daily supplementation with encapsulated fruit, vegetable and berry juice powder concentrates and clinical periodontal outcomes: a double-blind RCT. J Clin Periodontol (2011) 0.98
Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers. Nutr Res Pract (2011) 0.98
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.97
(+/-)-Naringenin as large conductance Ca(2+)-activated K+ (BKCa) channel opener in vascular smooth muscle cells. Br J Pharmacol (2006) 0.92
Is alcohol beneficial or harmful for cardioprotection? Genes Nutr (2010) 0.91
Does Ginkgo biloba reduce the risk of cardiovascular events? Circ Cardiovasc Qual Outcomes (2009) 0.90
Effects of flavonoid-containing beverages and EGCG on endothelial function. J Am Coll Nutr (2007) 0.89
A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol (2002) 0.87
Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery. Br J Pharmacol (2009) 0.86
Cultivar and Year Rather than Agricultural Practices Affect Primary and Secondary Metabolites in Apple Fruit. PLoS One (2015) 0.86
Lowering effects of onion intake on oxidative stress biomarkers in streptozotocin-induced diabetic rats. J Clin Biochem Nutr (2007) 0.85
Response of wild-type and high pigment-1 tomato fruit to UV-B depletion: flavonoid profiling and gene expression. Planta (2009) 0.84
Functional foods and nutraceuticals in the primary prevention of cardiovascular diseases. J Nutr Metab (2012) 0.84
A standardized bamboo leaf extract inhibits monocyte adhesion to endothelial cells by modulating vascular cell adhesion protein-1. Nutr Res Pract (2013) 0.84
AGING OF THE SUBVENTRICULAR ZONE NEURAL STEM CELL NICHE. Aging Dis (2011) 0.83
Antioxidant capacity of chewing stick miswak Salvadora persica. BMC Complement Altern Med (2013) 0.83
Inhibition of cardiac HERG channels by grapefruit flavonoid naringenin: implications for the influence of dietary compounds on cardiac repolarisation. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.83
The effects of quercetin supplementation on body composition, exercise performance and muscle damage indices in athletes. Int J Prev Med (2013) 0.83
Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugs. Cardiovasc Res (2012) 0.82
Alcohol consumption and non-Hodgkin lymphoma survival. J Cancer Surviv (2009) 0.82
Flavonoid intake and coronary mortality. Objective data trials are needed. BMJ (1996) 0.82
Estimated intake and major food sources of flavonoids among US adults: changes between 1999-2002 and 2007-2010 in NHANES. Eur J Nutr (2015) 0.82
A plant-based diet, atherogenesis, and coronary artery disease prevention. Perm J (2014) 0.81
Consumption of fruits and vegetables in relation to the risk of developing acute coronary syndromes; the CARDIO2000 case-control study. Nutr J (2003) 0.81
Pharmacological evidence for the activation of potassium channels as the mechanism involved in the hypotensive and vasorelaxant effect of dioclein in rat small resistance arteries. Br J Pharmacol (2001) 0.81
Upstream stimulatory factor-2 mediates quercetin-induced suppression of PAI-1 gene expression in human endothelial cells. J Cell Biochem (2010) 0.81
Gold color in onions (Allium cepa): a natural mutation of the chalcone isomerase gene resulting in a premature stop codon. Mol Genet Genomics (2004) 0.80
In vitro amoebicidal activity of four Allium species on Acanthamoeba castellanii and their cytotoxic potentials on corneal cells. Parasitol Res (2007) 0.80
Separation and Purification of Flavonoids from Black Currant Leaves by High-Speed Countercurrent Chromatography and Preparative HPLC. J Liq Chromatogr Relat Technol (2010) 0.80
Estimated daily intake and seasonal food sources of quercetin in Japan. Nutrients (2015) 0.80
Pomegranate Protection against Cardiovascular Diseases. Evid Based Complement Alternat Med (2012) 0.79
Potent inhibition of VEGFR-2 activation by tight binding of green tea epigallocatechin gallate and apple procyanidins to VEGF: relevance to angiogenesis. Mol Nutr Food Res (2015) 0.79
Procyanidin C1 causes vasorelaxation through activation of the endothelial NO/cGMP pathway in thoracic aortic rings. J Med Food (2014) 0.78
Quantitative Changes of Polyphenolic Compounds in Mulberry (Morus alba L.) Leaves in Relation to Varieties, Harvest Period, and Heat Processing. Prev Nutr Food Sci (2012) 0.78
Pink (P), a new locus responsible for a pink trait in onions (Allium cepa) resulting from natural mutations of anthocyanidin synthase. Mol Genet Genomics (2004) 0.78
Flavonol and flavone intake and the risk of intermittent claudication in male smokers. Eur J Epidemiol (2004) 0.78
Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech (2013) 0.77
A Review of Botanical Characteristics, Traditional Usage, Chemical Components, Pharmacological Activities, and Safety of Pereskia bleo (Kunth) DC. Evid Based Complement Alternat Med (2014) 0.77
Dietary flavonoid intake and cardiovascular risk: a population-based cohort study. J Transl Med (2015) 0.77
Amoebicidal activity of the rhizomes and aerial parts of Allium sivasicum on Entamoeba histolytica. Parasitol Res (2012) 0.77
Differing Relations to Early Atherosclerosis between Vitamin C from Supplements vs. Food in the Los Angeles Atherosclerosis Study: A Prospective Cohort Study. Open Cardiovasc Med J (2012) 0.77
Metabolic enzymes dysregulation in heart failure: the prospective therapy. Heart Fail Rev (2016) 0.76
Antioxidants and cardiovascular disease: Still a topic of interest. Environ Health Prev Med (2004) 0.76
At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury. Ann Transl Med (2016) 0.75
Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction. J Cardiovasc Pharmacol (2015) 0.75
Protective Effect of Onion Extract on Bleomycin-Induced Cytotoxicity and Genotoxicity in Human Lymphocytes. Int J Environ Res Public Health (2016) 0.75
Effects of dietary flavonoids intake in saudi patients with coronary heart disease. J Family Community Med (2007) 0.75
Association between Polyphenol Intake and Hypertension in Adults and Older Adults: A Population-Based Study in Brazil. PLoS One (2016) 0.75
Fruit Intake and Abdominal Aortic Calcification in Elderly Women: A Prospective Cohort Study. Nutrients (2016) 0.75
Relaxation of rat aorta by farrerol correlates with potency to reduce intracellular calcium of VSMCs. Int J Mol Sci (2014) 0.75
Flavonoid intake and coronary mortality. Other antinutritional factors may also have a role. BMJ (1996) 0.75
Terminalia bellirica Extract Inhibits Low-Density Lipoprotein Oxidation and Macrophage Inflammatory Response in Vitro. Antioxidants (Basel) (2016) 0.75
ACEMg Diet Supplement Modifies Progression of Hereditary Deafness. Sci Rep (2016) 0.75
Health-Beneficial Phenolic Aldehyde in Antigonon leptopus Tea. Evid Based Complement Alternat Med (2010) 0.75
The effect of anthocyanin supplementation on body composition, exercise performance and muscle damage indices in athletes. Int J Prev Med (2014) 0.75
Tea flavonoids have little short term impact on serum antioxidant activity. BMJ (1996) 0.75
Attenuation of reactive oxygen/nitrogen species with suppression of inducible nitric oxide synthase expression in RAW 264.7 macrophages by bark extract of Buchanania lanzan. Pharmacogn Mag (2015) 0.75
Encapsulation of catechin and epicatechin on BSA NPS improved their stability and antioxidant potential. EXCLI J (2014) 0.75
Bioactive Plant Metabolites in the Management of Non-Communicable Metabolic Diseases: Looking at Opportunities beyond the Horizon. Metabolites (2015) 0.75
Effects of Tannic Acid, Green Tea and Red Wine on hERG Channels Expressed in HEK293 Cells. PLoS One (2015) 0.75
Allium vegetable intake and risk of acute myocardial infarction in Italy. Eur J Nutr (2009) 0.75
No effect of the farming system (organic/conventional) on the bioavailability of apple (Malus domestica Bork., cultivar Golden Delicious) polyphenols in healthy men: a comparative study. Eur J Nutr (2009) 0.75
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet (1993) 6.53
Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med (1995) 3.90
Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet (1993) 3.72
Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med (1990) 1.74
Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol (1990) 1.72
The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl (1983) 1.59
On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol (1987) 1.43
Localization of angiotensin II receptors in ovarian follicles and the identification of angiotensin II in rat ovaries. Proc Natl Acad Sci U S A (1987) 1.31
Dietary fat and risk of breast cancer. Am J Clin Nutr (1990) 1.20
[The phenolics of fruits. VIII. Changes in flavonol concentrations during fruit development (authors transl)]. Z Lebensm Unters Forsch (1976) 1.06
The modification of low density lipoprotein by the flavonoids myricetin and gossypetin. Biochem Pharmacol (1993) 1.02
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet (2001) 10.29
Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J (1991) 6.35
Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia (1992) 5.25
Smoking and risk of rheumatoid arthritis. J Rheumatol (1993) 3.63
Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther (2007) 3.53
The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med (2000) 3.10
Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol (1991) 2.43
Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia (1998) 2.25
Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study. BMJ (1998) 2.16
Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr (2005) 2.14
Determinants of weight gain and overweight in adult Finns. Eur J Clin Nutr (1991) 2.04
Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men. Am J Hypertens (1998) 2.02
Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation (2007) 1.98
Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol (1994) 1.82
Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis (2000) 1.74
Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut (2008) 1.64
The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl (1983) 1.59
Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol (1996) 1.58
Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol (1997) 1.56
Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness. Eur J Clin Invest (2001) 1.54
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia (2005) 1.52
Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease? Arch Intern Med (2001) 1.50
Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol (1988) 1.45
Risk factors for injurious falls leading to hospitalization or death in a cohort of 19,500 adults. Am J Epidemiol (1993) 1.43
Validity of hospital discharge data in a prospective epidemiological study on stroke and myocardial infarction. Acta Med Scand (1984) 1.43
Reliability of perceived health by sex and age. Soc Sci Med (1999) 1.43
Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol (1988) 1.38
The epidemiology of insulin-dependent diabetes mellitus (IDDM) in Finland and in northern Europe. Diabetes Care (1985) 1.36
Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med (2009) 1.35
Prevalence and ten-year (1970-1979) incidence of insulin-dependent diabetes mellitus in children and adolescents in Finland. Acta Paediatr Scand (1982) 1.34
The epidemiology of hyperostosis of the spine together with its symptoms and related mortality in a general population. Scand J Rheumatol (1975) 1.34
Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl (1982) 1.34
Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst (1990) 1.33
Body iron stores and risk of cancer. Int J Cancer (1994) 1.31
Alcohol consumption and sudden coronary death in middle-aged Finnish men. Acta Med Scand (1987) 1.31
Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med (1999) 1.27
Rheumatoid factor, chronic arthritis and mortality. Ann Rheum Dis (1995) 1.26
Prediction of type 1 diabetes among siblings of affected children and in the general population. Diabetologia (2007) 1.24
Depression and cardiovascular diseases. Acta Psychiatr Scand Suppl (1994) 1.23
Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr (1996) 1.22
Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand (1982) 1.21
Risk of disability and mortality due to overweight in a Finnish population. BMJ (1990) 1.21
Musculoskeletal disorders as determinants of disability in Finns aged 30 years or more. J Clin Epidemiol (1993) 1.20
Epidemiology of childhood diabetes mellitus in Finland--background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia (1992) 1.20
Risk factors for sudden and non-sudden coronary death. Acta Med Scand (1988) 1.19
Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol (1991) 1.19
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol (1996) 1.18
Persistent organochlorine pesticides in serum and risk of Parkinson disease. Neurology (2010) 1.17
DNA replication studies with coliphage 186. III. A single phage gene is required for phage 186 replication. J Mol Biol (1990) 1.16
Increase in incidence of insulin-dependent diabetes mellitus among children in Finland. Int J Epidemiol (1995) 1.14
Weight and mortality in Finnish men. J Clin Epidemiol (1989) 1.13
Descriptive epidemiology and public health aspects of low back pain. Ann Med (1989) 1.10
Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med (2000) 1.09
Serum thyrotrophin and circulating thyroglobulin and thyroid microsomal antibodies in a Finnish population. Acta Endocrinol (Copenh) (1979) 1.09
Oral health indicators poorly predict coronary heart disease deaths. J Dent Res (2003) 1.08
Glycemic control in patients with diabetes in Finland. Diabetes Care (1999) 1.08
Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer (1998) 1.08
QT interval as a cardiac risk factor in a middle aged population. Heart (1997) 1.06
Increasing trend in type 1 (insulin-dependent) diabetes mellitus in childhood in Finland. Analysis of age, calendar time and birth cohort effects during 1965 to 1984. Diabetologia (1991) 1.06
Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer? Br J Cancer (2000) 1.04
Prevalence and risk factors of varicose veins in lower extremities: mini-Finland health survey. Eur J Surg (1995) 1.04
Structure and costs of health care of diabetic patients in Finland. Diabetes Care (1996) 1.04
Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int J Cancer (1988) 1.03
Is low selenium status a risk factor for lung cancer? Am J Epidemiol (1998) 1.03
Prevalence of mental disorders among adults in Finland: basic results from the Mini Finland Health Survey. Acta Psychiatr Scand (1990) 1.02
Serum cholesterol and risk of rheumatoid arthritis in a cohort of 52 800 men and women. Br J Rheumatol (1996) 1.02
Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J (1992) 1.02
Clinical arthritis associated with positive radiological and serological findings in Finnish adults. Rheumatol Int (1989) 1.02
Pulse wave velocity reference values in healthy adults aged 26-75 years. Clin Physiol Funct Imaging (2007) 1.00
Hospital use among diabetic patients and the general population. Diabetes Care (1994) 0.99
Serum cholesterol and triglyceride concentrations of Finns and Finnish Lapps. I. Basic data. Acta Med Scand (1975) 0.99
Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study. Cancer (1999) 0.98
Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr (2007) 0.98
Recent trends in the consumption of lipid-lowering drugs in Finland. J Clin Epidemiol (1996) 0.98
Poor applicability of the Friedewald formula in the assessment of serum LDL cholesterol for clinical purposes. Clin Biochem (1995) 0.98
Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol (1995) 0.97
Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am J Epidemiol (1990) 0.96
Serum immunoglobulins and the risk of rheumatoid arthritis. Ann Rheum Dis (1997) 0.95
Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987. Am J Epidemiol (1991) 0.95
Parity and risk of rheumatoid arthritis in Finnish women. Br J Rheumatol (1995) 0.94
Prevalence of stroke in Finland. Stroke (1986) 0.94
Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren. Diabetologia (2000) 0.93
Quercetin intake and the incidence of cerebrovascular disease. Eur J Clin Nutr (2000) 0.93
Smoking and risk of colorectal cancer. Br J Cancer (1998) 0.93
Mortality in type 2 diabetes. Ann Clin Res (1983) 0.92
Serum cholesterol concentration and risk of primary brain tumours. BMJ (1991) 0.91
Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study. Scand J Clin Lab Invest (2008) 0.91
Vitamin E and cancer prevention. Am J Clin Nutr (1991) 0.90
The metabolic syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 Study. Diabetes Metab (2010) 0.90
Serum micronutrients and risk of cancers of low incidence in Finland. Am J Epidemiol (1991) 0.90
Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening. Cancer (1993) 0.90